Literature DB >> 6238927

Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VI. Chemical degradation: physico-chemical and biological properties of acid hydrolysis products.

A Malabarba, P Strazzolini, A Depaoli, M Landi, M Berti, B Cavalleri.   

Abstract

Teicoplanin is an antibiotic complex consisting of five closely related factors, T-A2-1, 2, 3, 4 and 5 and a more polar factor, T-A3-1. By controlled acid hydrolysis the complex is transformed into pseudoaglycones and finally into a single aglycone with consecutive removal of three sugar units. Quantitative determination of sugars obtained by degradative reactions and NMR/LC-MS studies on suitable derivatives confirmed that all the components carry one N-acyl-D-glucosamine and that at least two of them are characterized by N-decanoyl and N-undecanoyl chains on the D-glucosamine unit. The hydrolysis products still possess in vitro and in vivo activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238927     DOI: 10.7164/antibiotics.37.988

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  12 in total

Review 1.  Antibacterial activities and modes of action of vancomycin and related glycopeptides.

Authors:  R Nagarajan
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Activity of glycopeptides against vancomycin-resistant gram-positive bacteria.

Authors:  T I Nicas; C T Cole; D A Preston; A A Schabel; R Nagarajan
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

3.  Genetic and Transcriptional Analyses of the Flagellar Gene Cluster in Actinoplanes missouriensis.

Authors:  Moon-Sun Jang; Yoshihiro Mouri; Kaoru Uchida; Shin-Ichi Aizawa; Masayuki Hayakawa; Nobuyuki Fujita; Takeaki Tezuka; Yasuo Ohnishi
Journal:  J Bacteriol       Date:  2016-07-28       Impact factor: 3.490

4.  Thermodynamic analysis of the interaction of the antibiotic teicoplanin and its aglycone with cell-wall peptides.

Authors:  P Arriaga; J Laynez; M Menendez; J Cañada; F Garcia-Blanco
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

5.  Teicoplanin metabolism in rats.

Authors:  L F Zerilli; L Cavenaghi; A Bernareggi; A Assandri
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of teicoplanin.

Authors:  M Rowland
Journal:  Clin Pharmacokinet       Date:  1990-03       Impact factor: 6.447

7.  Pharmacokinetics of individual components of teicoplanin in man.

Authors:  A Bernareggi; A Danese; A Cometti; G Buniva; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1990-12

8.  Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers.

Authors:  P L Carver; C H Nightingale; R Quintiliani; K Sweeney; R C Stevens; E Maderazo
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

9.  Charge and lipophilicity govern the pharmacokinetics of glycopeptide antibiotics.

Authors:  D H Pitkin; B A Mico; R D Sitrin; L J Nisbet
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

10.  Actinoplanes teichomyceticus ATCC 31121 as a cell factory for producing teicoplanin.

Authors:  Carlo Taurino; Luca Frattini; Giorgia Letizia Marcone; Luciano Gastaldo; Flavia Marinelli
Journal:  Microb Cell Fact       Date:  2011-10-18       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.